Kerr Douglas
Reporting owner on Forms 3, 4 and 5, CIK 1814189.
Kerr Douglas reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| DYN · Dyne Therapeutics, Inc.CIK 1818794 | officer (Head of R&D and CMO) | 2 | 2026-11-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| DYN · Dyne Therapeutics, Inc.Common Stock | 2026-11-13 | S sold | -2,604 | $16.82 | 167,960 | Form 4 |
| DYN · Dyne Therapeutics, Inc.Common Stock | 2026-10-20 | A granted | +8,000 | $0 | 170,564 | Form 4 |
| DYN · Dyne Therapeutics, Inc.Stock option (right to buy), derivative | 2026-10-20 | A granted | +12,000 | $0 | 12,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001814189-26-000009 | Dyne Therapeutics, Inc. | 2026-11-16 | ||
| Form 4 0001814189-26-000007 | Dyne Therapeutics, Inc. | 2026-10-22 |